Low levels of SMP30 are found to be related to poor OS rate of HCC patients, as revealed by the Roessler Liver 2 dataset (P = 0.0059)8 (Fig. 4b), suggesting that down-regulated SMP30 gene expression predicted poor prognosis of HCC patients. This evidence concerns the gene RGN and hepatocellular carcinoma.